Clopidogrel for Smokers and Aspirin for Nonsmokers?: Not So Fast

    loading  Checking for direct PDF access through Ovid

Abstract

New data solidify a “smoker's paradox” for clopidogrel, with current smokers appearing to respond better than nonsmokers. However, the clinical implications of this finding are unclear. This Commentary discusses the new data and puts it into clinical context.

Related Topics

    loading  Loading Related Articles